Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ASX/CAN stock hub

ASX/CAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/CANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.1M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/CAN

In the news

Latest news · ASX/CAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/E0.2

P25 14.2P50 19.2P75 35.1

ROE72.6

P25 -118.7P50 -49.4P75 -1.2

ROIC-14.2

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/CAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

AUD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Enterprise value	AUD 22.1M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	AU000000CAN2
Last refreshed	2026-05-10
Market cap	AUD 8.1M
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
Sic	2834
Symbol	asx/CAN
Website	https://www.canngrouplimited.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	182.75%
EV Earnings	1.5x
EV/FCF	-4.16x
EV/Sales	1.95x
FCF yield	-65.88%
P/B ratio	0.24x
P/E ratio	0.24x
P/S ratio	0.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-128.75%
EBITDA Margin	-64.02%
Gross margin	45.61%
Gross Profit	AUD 5.2M
Gross Profit Growth	0.08%
Gross Profit Growth Q	0.13%
Gross Profit Growth3 Y	-5.85%
Gross Profit Growth5 Y	-1.42%
Net Income	AUD 14.7M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	130.29%
Profit Margin	130.29%
ROA	-12.95
Roa5y	-13.12
ROCE	-42.18
ROE	72.56
Roe5y	-130.1
ROIC	-14.23

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-68.77%
Cagr3y	-67.82%
Cagr5y	-59.52%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth	-27.08x
Revenue Growth Q	-30.09x
Revenue Growth Years	0x
Revenue Growth3 Y	-14.92x
Revenue Growth5 Y	-11.33x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.16
Assets	AUD 55.5M
Cash	AUD 955,000
Current Assets	AUD 8.9M
Current Liabilities	AUD 21M
Debt	AUD 15M
Debt Equity	AUD 0.44
Debt FCF	AUD -2.82
Equity	AUD 34.3M
Interest Coverage	-1.96
Liabilities	AUD 21.3M
Long Term Assets	AUD 46.6M
Long Term Liabilities	AUD 235,000
Net Cash	AUD -14M
Net Cash By Market Cap	AUD -174
Net Debt Equity	AUD 0.41
Tangible Book Value	AUD 34.3M
Tangible Book Value Per Share	AUD 0.02
WACC	27.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.42
Inventory Turnover	0.93
Net Working Capital	AUD 1.9M
Quick ratio	0.09
Working Capital	AUD -12.1M
Working Capital Turnover	AUD -0.29

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-54.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-68.75%
200-day SMA	0.01
3Y total return	-96.67%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.91%
All Time High	4.55
All Time High Change	-99.89%
All Time High Date	2018-01-05
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2026-03-23
ATR	0
Beta	0.15
Beta1y	0.02
Beta2y	0.41
Ch YTD	-44.44
High	0.01
High52	0.02
High52 Date	2025-09-26
High52ch	-78.26%
Low	0.01
Low52	0.01
Low52 Date	2026-05-08
Low52ch	0%
Ma50ch	-16.67%
Price vs 200-day SMA	-49.49%
RSI	42.71
RSI Monthly	32.57
RSI Weekly	33.46
Sharpe ratio	-0.17x
Sortino ratio	-0.23
Total Return	-54.37%
Tr YTD	-44.44
Tr1m	-16.67%
Tr3m	-37.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -14.6M
Operating margin	-128.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,343,883,330%
Net Borrowing	-2,955,000
Shares Insiders	5.91%
Shares Institutions	0.36%
Shares Out	1,612,231,816
Shares Qo Q	45.17%
Shares Yo Y	54.37%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -5.6M
Average Volume	3,649,208.85x
Bv Per Share	0.02
CAPEX	AUD -193,000
Ch1m	-16.67
Ch1y	-68.75
Ch3m	-37.5
Ch3y	-96.88
Ch5y	-98.98
Ch6m	-54.55
Change	0%
Change From Open	-16.67
Close	0.01
Days Gap	20
Depreciation Amortization	7,319,000
Dollar Volume	2,876.3
Earnings Date	2026-05-28
EBIT	AUD -14.6M
EBITDA	AUD -7.2M
EPS	AUD 0.02
F Score	4
FCF	AUD -5.3M
FCF EV Yield	-24.07x
FCF Per Share	AUD -0
Financing CF	6,208,000
Fiscal Year End	June
Founded	2,014
Graham Number	0.10112
Graham Upside	1,922.4
Investing CF	-193,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	0.01
Ma150ch	-43.18%
Ma20	0.01
Ma20ch	-7.41%
Net CF	895,000
Next Earnings Date	2026-05-28
Open	0.01
Position In Range	0
Ppne	46,583,000
Price Date	2026-05-08
Ptbv Ratio	0.24
Relative Volume	0.15x
Revenue	11,307,000x
SBC By Revenue	2.87x
Share Based Comp	325,000
Tr6m	-54.55%
Volume	575,262
Z Score	-4.77

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/CAN pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/CAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/CAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

+5.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+54.4%

Negative means the company is buying back shares.

Technical

ASX/CAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.7

Neutral momentum band

Price vs 200-day MA

-49.5%

50/200-day relationship not available

Beta (5Y)

0.15

Less volatile than the market

Sharpe ratio

-0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/CAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/CAN stock rating?

asx/CAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/CAN analysis?

The full report lives at /stocks/asx/CAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/CAN?

The latest report frames asx/CAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/CAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.